243 Results for "

DM-

" in MedChemExpress (MCE) Product Catalog:
Products (243)

243 Results for "DM-" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-120140
CAS No.: 173075-45-1
Purity:  99.65%
Ganoderic acid DM, a natural triterpenoid isolated from Ganoderma lucidum, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Ganoderic acid DM as a specific inhibitor of osteoclastogenesis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-100665
CAS No.: 129722-25-4
Purity:  99.66%
Synonyms: OPC-14857; DM-14857
Research Areas:  

Neurological Disease

Dehydroaripiprazole (OPC-14857) is an active metabolite of Aripiprazole (HY-14546) and dopamine D2/D3 receptor partial agonist. Dehydroaripiprazole also has certain affinity for serotonin 5-HT1A, 5-HT2A and 5-HT2B receptors. Dehydroaripiprazole has antipsychotic activity equivalent to Aripiprazole .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148818
CAS No.: 890654-03-2
Purity:  99.03%
Target:  

ADC Payloads

Research Areas:  

Others

S-Me-DM4 is a metabolite of DM4 S-methylated by intracellular enzyme. DM4 (HY-100503) is a microtubule-depolymerizing maytansinoid with strong cytotoxicity. DM4 can be used as an ADC Cytotoxin molecule .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99493
CAS No.: 868747-45-9
Synonyms: IMGN242; huC242-DM4
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (HY-12454). Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141607
CAS No.: 1238517-16-2
Purity:  99.09%
Synonyms: BT-062; nBT062-DM4
Research Areas:  

Cancer

Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) based on a murine/human chimeric form of B-B4 (specific for CD138), linked to the maytansinoid agent DM4 by disulphide bonds. Indatuximab ravtansine shows anti-tumor activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99542
CAS No.: 2254086-60-5
Synonyms: SAR-408701; HuMAb2-3-SPDB-DM4
Tusamitamab ravtansine (SAR-408701) is a targeted ADC against tumor cells expressing CEACAM5, composed of a humanized anti-CEACAM5 monoclonal antibody covalently linked to the potent cytotoxic agent, maytansinoid DM4 (HY-12454), via a cleavable linker. Tusamitamab ravtansine has an average drug-to-antibody ratio (DAR) of 3.8 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19947
CAS No.: 1393124-08-7
Synonyms: Glucagon receptor antagonists-4
Target:  

GCGR

Research Areas:  

Metabolic Disease

PF-06291874 is a highly potent, non-peptide and orally active glucagon receptor antagonist. PF-06291874 is under the study for type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112668
CAS No.: 1256756-88-3
Purity:  99.71%
Synonyms: SP2086 phosphate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112668A
CAS No.: 1174122-54-3
Purity:  98.51%
Synonyms: SP2086
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15408
CAS No.: 865759-25-7
Purity:  99.54%
Synonyms: SYR-472
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Trelagliptin (SYR-472) is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10449A
CAS No.: 1152425-66-5
Purity:  99.20%
Synonyms: TS 071 hydrate
Target:  

SGLT

Research Areas:  

Metabolic Disease

Luseogliflozin (TS 071) hydrate is a selective potent and orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor with an IC50 of 2.26 nM. Luseogliflozin hydrate can be used for the research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-15408A
CAS No.: 1029877-94-8
Purity:  99.96%
Synonyms: SYR-472 succinate
Target:  

Dipeptidyl Peptidase

Research Areas:  

Metabolic Disease

Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19835
CAS No.: 1423018-12-5
Research Areas:  

Metabolic Disease

LY2922470 is a selective and orally active agonist for the G protein-coupled receptor 40 (GPR40). LY2922470 activates GPR40-mediated β-arrestin recruitment with EC50s of 7 nM (human GPR40), 1 nM (mouse GPR40) and 3 nM (rat GPR40). LY2922470 can be used for research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1021
CAS No.: 1617-90-9
Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation . Vincamine is a GPR40 agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P990001
Anti-Mouse IL-10 Antibody (JES5-2A5) is an anti-mouse IL-10 IgG1 monoclonal antibody. Anti-Mouse IL-10 Antibody (JES5-2A5) restores the anti-tumor activity of IL-6 by blocking the IL-10/SOCS3 axis. Anti-Mouse IL-10 Antibody (JES5-2A5) can reverse microcirculation and cognitive deficits. Anti-Mouse IL-10 Antibody (JES5-2A5) can be used for researches on cancer and metabolic disease such as osteosarcoma and type 1 diabetes mellitus (T1DM) .
loading...
    loading...
Cat. No.: HY-128915
CAS No.: 1116745-06-2
Purity:  99.69%
Research Areas:  

Cancer

Duocarmycin DM free base, a DNA minor-groove alkylator, is an antibody agent conjugates (ADCs) toxin. Duocarmycin DM free base is based on its characteristic curved indole structure and a spirocyclopropylcyclohexadienone electrophile to act anticancer activity .
loading...
    loading...
Cat. No.: HY-137234
CAS No.: 51166-71-3
Purity:  99.9%
Synonyms: 2,6-Di-O-methyl-β-cyclodextrin
DM-β-CD (2,6-Di-O-methyl-β-cyclodextrin) is a cyclic molecule consisting of seven glucose units modified with two methyl groups at the 2- and 6-positions. It is usually used as a solubilizer and carrier for poorly soluble drugs in pharmaceutical preparations. Furthermore, it has applications in analytical chemistry, food science, and environmental remediation due to its ability to form clathrates with various guest molecules, such as aromatic compounds, pesticides, and heavy metals.
loading...
    loading...
Cat. No.: HY-126491
CAS No.: 452072-20-7
Purity:  ≥95.0%
Research Areas:  

Cancer

SPP-DM1 is a agent-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPP .
loading...
    loading...
Cat. No.: HY-B0340
CAS No.: 77191-36-7
Synonyms: DM9384; DZL-221
Nefiracetam is a cognition-enhancing agent. Nefiracetam is an activator of nAChR, N-methyl-D-aspartate receptor (NMDAR), mGluR5, PKC, gamma-aminobutyric acid (GABA), and N/L-type Ca 2+ channels. Nefiracetam promotes neuroplasticity and enhances neuroprotection. Nefiracetam can be used in Alzheimer's disease, epilepsy, and cerebral ischemia research .
loading...
    loading...
Cat. No.: HY-136286
CAS No.: 1375089-56-7
Purity:  99.50%
Research Areas:  

Cancer

MC-DM1 is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody agent conjugate (ADC) .
loading...
    loading...